KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Liabilities and Shareholders Equity (2016 - 2026)

Bristol Myers Squibb has reported Liabilities and Shareholders Equity over the past 18 years, most recently at $86.5 billion for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 6.44% to $86.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $368.1 billion through Mar 2026, down 1.41% year-over-year, with the annual reading at $90.0 billion for FY2025, 2.77% down from the prior year.
  • Liabilities and Shareholders Equity was $86.5 billion for Q1 2026 at Bristol Myers Squibb, down from $90.0 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $103.0 billion in Q1 2022 and troughed at $86.5 billion in Q1 2026.
  • The 5-year median for Liabilities and Shareholders Equity is $94.6 billion (2024), against an average of $94.9 billion.
  • Year-over-year, Liabilities and Shareholders Equity dropped 11.45% in 2022 and then grew 5.04% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $96.8 billion in 2022, then decreased by 1.72% to $95.2 billion in 2023, then decreased by 2.69% to $92.6 billion in 2024, then dropped by 2.77% to $90.0 billion in 2025, then decreased by 3.96% to $86.5 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Liabilities and Shareholders Equity are $86.5 billion (Q1 2026), $90.0 billion (Q4 2025), and $96.9 billion (Q3 2025).